| scholarly article | Q13442814 |
| P50 | author | Geoffrey Ian McFadden | Q21520235 |
| Danny W Wilson | Q56476038 | ||
| James Beeson | Q56780488 | ||
| P2093 | author name string | Christine Langer | |
| Christopher D Goodman | |||
| P2860 | cites work | Artemisinin Resistance in Plasmodium falciparum Malaria | Q22061852 |
| Artemisinins target the SERCA of Plasmodium falciparum | Q22061877 | ||
| Human malaria parasites in continuous culture | Q28131626 | ||
| Subcellular discharge of a serine protease mediates release of invasive malaria parasites from host erythrocytes | Q30043441 | ||
| A multifunctional serine protease primes the malaria parasite for red blood cell invasion | Q30043444 | ||
| Artemisinin induces calcium-dependent protein secretion in the protozoan parasite Toxoplasma gondii | Q30480935 | ||
| Monitoring Plasmodium falciparum growth and development by UV flow cytometry using an optimized Hoechst-thiazole orange staining strategy. | Q33321282 | ||
| Neither heparin nor acetylsalicylic acid influence the clinical course in human Plasmodium falciparum malaria: a prospective randomized study | Q33384958 | ||
| A comparative study of a flow-cytometry-based assessment of in vitro Plasmodium falciparum drug sensitivity | Q33562855 | ||
| Development of fluorescent Plasmodium falciparum for in vitro growth inhibition assays | Q33939788 | ||
| Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum | Q34002708 | ||
| Isolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development | Q34069682 | ||
| Antiparasitic agent atovaquone | Q34107885 | ||
| A rapid and robust tri-color flow cytometry assay for monitoring malaria parasite development | Q34166626 | ||
| Artemisinin‐induced dormancy in plasmodium falciparum: duration, recovery rates, and implications in treatment failure | Q34172447 | ||
| Comparative gene expression profiling of P. falciparum malaria parasites exposed to three different histone deacetylase inhibitors | Q34181991 | ||
| Pathogenesis of Plasmodium falciparum malaria: the roles of parasite adhesion and antigenic variation | Q34578090 | ||
| Malaria parasite exit from the host erythrocyte: a two-step process requiring extraerythrocytic proteolysis | Q34593913 | ||
| Apicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance in Toxoplasma gondii. | Q35102319 | ||
| Artemisinins: mechanisms of action and potential for resistance | Q35943361 | ||
| Parasite ligand-host receptor interactions during invasion of erythrocytes by Plasmodium merozoites | Q35975131 | ||
| Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast | Q36095096 | ||
| Primaquine-induced changes in morphology of exoerythrocytic stages of malaria | Q36567481 | ||
| Towards histone deacetylase inhibitors as new antimalarial drugs. | Q38011212 | ||
| New approaches to studying Plasmodium falciparum merozoite invasion and insights into invasion biology | Q38065630 | ||
| Drug sensitivity of plasmodium falciparum. An in-vitro microtechnique | Q39471565 | ||
| Plasmodium falciparum: Merozoite invasion in vitro in the presence of chloroquine | Q40977686 | ||
| Stage-dependent inhibition of chloroquine on Plasmodium falciparum in vitro. | Q41914764 | ||
| Digestion of the host erythrocyte by malaria parasites is the primary target for quinoline-containing antimalarials | Q41915204 | ||
| Differential effects of 4-aminoquinoline-containing antimalarial drugs on hemoglobin digestion in Plasmodium falciparum-infected erythrocytes | Q41917894 | ||
| Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and other quinoline antimalarials | Q41924367 | ||
| Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite | Q41929069 | ||
| Interactions with heparin-like molecules during erythrocyte invasion by Plasmodium falciparum merozoites | Q43134710 | ||
| Mitochondria as the site of action of tetracycline on Plasmodium falciparum | Q43484102 | ||
| Selective inhibition of a two-step egress of malaria parasites from the host erythrocyte | Q44511093 | ||
| Double staining of Plasmodium falciparum nucleic acids with hydroethidine and thiazole orange for cell cycle stage analysis by flow cytometry | Q44709525 | ||
| Artemisinin-resistant malaria in Asia. | Q45916491 | ||
| The effects of anti-bacterials on the malaria parasite Plasmodium falciparum. | Q47823743 | ||
| Mathematical modelling of the chemotherapy of Plasmodium falciparum malaria with artesunate: postulation of 'dormancy', a partial cytostatic effect of the drug, and its implication for treatment regimens | Q47874225 | ||
| Super-resolution dissection of coordinated events during malaria parasite invasion of the human erythrocyte | Q47970034 | ||
| Plasmodium knowlesi: studies on invasion of rhesus erythrocytes by merozoites in the presence of protease inhibitors | Q47988661 | ||
| Plasmodium berghei dihydrofolate reductase. Isolation, properties, and inhibition by antifolates | Q68742555 | ||
| Plasmodium falciparum: protease inhibitors and inhibition of erythrocyte invasion | Q68916531 | ||
| Effects of Antibiotics on Plasmodium Falciparum in Vitro * | Q70249157 | ||
| Requirement of malarial protease in the invasion of human red cells by merozoites of Plasmodium falciparum | Q70272957 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Plasmodium falciparum | Q311383 |
| antimalarial | Q521616 | ||
| P1104 | number of pages | 13 | |
| P304 | page(s) | 1455-1467 | |
| P577 | publication date | 2013-01-14 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Defining the timing of action of antimalarial drugs against Plasmodium falciparum | |
| P478 | volume | 57 |
| Q37700104 | 4-Nitro styrylquinoline is an antimalarial inhibiting multiple stages of Plasmodium falciparum asexual life cycle |
| Q102371670 | A Novel Hybrid of Chloroquine and Primaquine Linked by Gold(I): Multitarget and Multiphase Antiplasmodial Agent |
| Q36396055 | A portable image-based cytometer for rapid malaria detection and quantification |
| Q57296217 | A reference document on Permissible Limits for solvents and buffers during in vitro antimalarial screening |
| Q28550911 | Activity of herbal medicines on Plasmodium falciparum gametocytes: Implications for Malaria transmission in Ghana |
| Q98385970 | Analysis of erythrocyte signalling pathways during Plasmodium falciparum infection identifies targets for host-directed antimalarial intervention |
| Q33726679 | Bioluminescence Method for In Vitro Screening of Plasmodium Transmission-Blocking Compounds |
| Q56358841 | Cellular dissection of malaria parasite invasion of human erythrocytes using viable Plasmodium knowlesi merozoites |
| Q93271193 | Cellular thermal shift assay for the identification of drug-target interactions in the Plasmodium falciparum proteome |
| Q91782044 | Combining Stage Specificity and Metabolomic Profiling to Advance Antimalarial Drug Discovery |
| Q37680869 | Cytometric measurement of in vitro inhibition of Plasmodium falciparum field isolates by drugs: a new approach for re-invasion inhibition study. |
| Q92983262 | DNA Methylation Bisubstrate Inhibitors Are Fast-Acting Drugs Active against Artemisinin-Resistant Plasmodium falciparum Parasites |
| Q89494123 | DeepMalaria: Artificial Intelligence Driven Discovery of Potent Antiplasmodials |
| Q40649128 | Defining the Effectiveness of Antimalarial Chemotherapy: Investigation of the Lag in Parasite Clearance Following Drug Administration |
| Q35060339 | Efficacy of intranasal administration of artesunate in experimental cerebral malaria |
| Q37348404 | Fast in vitro methods to determine the speed of action and the stage-specificity of anti-malarials in Plasmodium falciparum |
| Q37707381 | Gellan sulfate inhibits Plasmodium falciparum growth and invasion of red blood cells in vitro. |
| Q48095893 | Heterologous Expression of a Novel Drug Transporter from the Malaria Parasite Alters Resistance to Quinoline Antimalarials. |
| Q34443423 | High yield purification of Plasmodium falciparum merozoites for use in opsonizing antibody assays |
| Q47193275 | High-Content Screening of MMV Pathogen Box for Plasmodium falciparum Digestive Vacuole Disrupting Molecules Reveals Valuable Starting Points for Drug Discovery. |
| Q64071781 | Identification of Bis-Cyclic Guanidines as Antiplasmodial Compounds from Positional Scanning Mixture-Based Libraries |
| Q48005441 | Identification of Heparin Modifications and Polysaccharide Inhibitors of Plasmodium falciparum Merozoite Invasion That Have Potential for Novel Drug Development |
| Q52659761 | Imidazolopiperazines Kill both Rings and Dormant Rings in Wild-Type and K13 Artemisinin-Resistant Plasmodium falciparum In Vitro. |
| Q48019234 | Inhibiting the Plasmodium eIF2α Kinase PK4 Prevents Artemisinin-Induced Latency |
| Q33662226 | Initiation of gametocytogenesis at very low parasite density in Plasmodium falciparum infection. |
| Q92170025 | Ivermectin Impairs the Development of Sexual and Asexual Stages of Plasmodium falciparum In Vitro |
| Q47917198 | Loading antimalarial drugs into noninfected red blood cells: an undesirable roommate for Plasmodium |
| Q30658099 | Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum |
| Q26772878 | Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria |
| Q36174228 | New Assays to Characterise Growth-Related Phenotypes of Plasmodium falciparum Reveal Variation in Density-Dependent Growth Inhibition between Parasite Lines |
| Q90371786 | PfCERLI1 is a conserved rhoptry associated protein essential for Plasmodium falciparum merozoite invasion of erythrocytes |
| Q36200165 | Plasmodium parasites mount an arrest response to dihydroartemisinin, as revealed by whole transcriptome shotgun sequencing (RNA-seq) and microarray study |
| Q22061938 | Pumped up: reflections on PfATP6 as the target for artemisinins |
| Q36528061 | Quantitative phospho-proteomics reveals the Plasmodium merozoite triggers pre-invasion host kinase modification of the red cell cytoskeleton. |
| Q56403247 | Recent updates in the discovery and development of novel antimalarial drug candidates |
| Q37643916 | Sequential processing of merozoite surface proteins during and after erythrocyte invasion by Plasmodium falciparum |
| Q46310228 | Shining new light on ancient drugs: preparation and subcellular localisation of novel fluorescent analogues of Cinchona alkaloids in intraerythrocytic Plasmodium falciparum |
| Q36724073 | Spirocyclic chromanes exhibit antiplasmodial activities and inhibit all intraerythrocytic life cycle stages |
| Q100761990 | Spirofused tetrahydroisoquinoline-oxindole hybrids as a novel class of fast acting antimalarial agents with multiple modes of action |
| Q56339840 | Superior Pyronaridine Single-Dose Pharmacodynamics Compared to Artesunate, Chloroquine, and Amodiaquine in a Murine Malaria Luciferase Model |
| Q48022900 | Targeted Phenotypic Screening in Plasmodium falciparum and Toxoplasma gondii Reveals Novel Modes of Action of Medicines for Malaria Venture Malaria Box Molecules. |
| Q64264199 | Targeting malaria parasite invasion of red blood cells as an antimalarial strategy |
| Q36051237 | The Redox Cycler Plasmodione Is a Fast-Acting Antimalarial Lead Compound with Pronounced Activity against Sexual and Early Asexual Blood-Stage Parasites |
| Q28541891 | Treatment of erythrocytes with the 2-cys peroxiredoxin inhibitor, Conoidin A, prevents the growth of Plasmodium falciparum and enhances parasite sensitivity to chloroquine |
| Q93025977 | Trichostatin A induces Trypanosoma cruzi histone and tubulin acetylation: effects on cell division and microtubule cytoskeleton remodelling |
| Q89766028 | Whole Cell Phenotypic Screening Of MMV Pathogen Box identifies Specific Inhibitors of Plasmodium falciparum late-stage development and egress |
Search more.